Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
74.50
+1.44 (1.97%)
Nov 22, 2024, 4:00 PM EST - Market closed
PRAX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 1.61 | 2.45 | - | - | - | - | Upgrade
|
| Cost of Revenue | 114.51 | 86.77 | 154.44 | - | - | - | Upgrade
|
| Gross Profit | -112.91 | -84.32 | -154.44 | - | - | - | Upgrade
|
| Selling, General & Admin | 51.11 | 42.05 | 59.55 | 47.08 | 16.99 | 6.23 | Upgrade
|
| Research & Development | - | - | - | 120.26 | 44.98 | 29.56 | Upgrade
|
| Operating Expenses | 51.11 | 42.05 | 59.55 | 167.33 | 61.97 | 35.79 | Upgrade
|
| Operating Income | -164.02 | -126.37 | -213.99 | -167.33 | -61.97 | -35.79 | Upgrade
|
| Interest & Investment Income | 9.38 | 3.14 | 1.96 | 2.36 | 0.14 | 0.19 | Upgrade
|
| EBT Excluding Unusual Items | -154.64 | -123.23 | -212.03 | -164.97 | -61.83 | -35.6 | Upgrade
|
| Merger & Restructuring Charges | - | - | -1 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.62 | -0.05 | -1 | -2.09 | - | - | Upgrade
|
| Pretax Income | -151.02 | -123.28 | -214.03 | -167.06 | -61.83 | -35.6 | Upgrade
|
| Income Tax Expense | - | - | - | - | -0.01 | -0.08 | Upgrade
|
| Net Income | -151.02 | -123.28 | -214.03 | -167.06 | -61.82 | -35.51 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 8.5 | 5.17 | Upgrade
|
| Net Income to Common | -151.02 | -123.28 | -214.03 | -167.06 | -70.32 | -40.68 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 7 | 3 | 3 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 7 | 3 | 3 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 196.72% | 114.58% | 8.58% | 374.34% | 485.12% | 17.88% | Upgrade
|
| EPS (Basic) | -9.95 | -18.69 | -69.65 | -59.03 | -117.86 | -398.94 | Upgrade
|
| EPS (Diluted) | -9.95 | -18.69 | -69.65 | -59.03 | -117.86 | -398.94 | Upgrade
|
| Free Cash Flow | -99.55 | -111.19 | -185.49 | -125.6 | -52.62 | -33.52 | Upgrade
|
| Free Cash Flow Per Share | -6.56 | -16.86 | -60.36 | -44.38 | -88.19 | -328.74 | Upgrade
|
| Operating Margin | -10219.00% | -5164.41% | - | - | - | - | Upgrade
|
| Profit Margin | -9409.22% | -5037.88% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -6202.24% | -4543.77% | - | - | - | - | Upgrade
|
| EBITDA | -163.59 | -125.94 | -213.57 | -167.15 | -61.92 | -35.75 | Upgrade
|
| D&A For EBITDA | 0.42 | 0.43 | 0.42 | 0.18 | 0.05 | 0.04 | Upgrade
|
| EBIT | -164.02 | -126.37 | -213.99 | -167.33 | -61.97 | -35.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.